Mylan CEO defends EpiPen price hike in congressional hearing
The fight over the price of the EpiPen, an emergency treatment device for severe allergic reactions, has officially reached Capitol Hill. CEO Heather Bresch of Mylan, the company that makes the EpiPen, defended the drug's drastic price increase during a congressional hearing Wednesday as a balance between "price and access," pointing out that Mylan only profits $50 for each two-pack sold and that it has in the past distributed EpiPens to schools for free.
"Looking back, I wish we had better anticipated the magnitude and acceleration of the rising financial issues for a growing minority of patients, who may have ended up paying the [list price] or more. We never intended this," Bresch said in a statement released ahead of the hearing.
Rep. Elijah Cummings (D-Md.) accused Mylan of raising the price of a potentially lifesaving drug — despite keeping its ingredients virtually unchanged — when it acquired EpiPen in 2007, in order "to get filthy rich at the expense of our constituents." Cummings also compared Mylan's tactics to those of Martin Shkreli, the widely-loathed pharmaceutical executive who raised the price of a lifesaving cancer and HIV drug by 5,000 percent.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Since Mylan acquired EpiPen, the price of the device has risen more than 500 percent, to $608 for a two-pack.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
The Week Unwrapped: will the US end child marriage?
Podcast Why some states have no lower limit on marriage age, plus Black maternal health and the price of olive oil
By The Week Staff Published
-
Perplexity AI: has Google finally met its match?
In The Spotlight Generative AI start-up provides fast, Wikipedia-like responses to search queries
By Chas Newkey-Burden, The Week UK Published
-
Quiz of The Week: 4 - 10 May
Puzzles and Quizzes Have you been paying attention to The Week's news?
By The Week Staff Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published